Emerging therapies of hemangioblastomas-Reference-Cited by-同舟云学术

Emerging therapies of hemangioblastomas

Published:2023-12-29 Issue:6 Volume:2 Page:318-330
ISSN:
Container-title:Exploration of Neuroscience
language:en
Short-container-title:Explor Neurosci

Author:

Sanghadia Chaitanya¹^ORCID,Martinez Melanie E.²^ORCID,McNulty Marisa³^ORCID,Russ Eric³^ORCID,Woolridge Maxwell³,Cao Dat Thanh³^ORCID,Micunovic Marko³^ORCID,Roberts Jeffery⁴,Perez Juan³,Lucke-Wold Brandon³^ORCID

Affiliation:

1. Department of Molecular and Cellular Biology, University of Arizona, Tucson, Arizona 85721, USA

2. Department of Neuroscience, University of Florida, Gainesville, Florida 32611, USA

3. Department of Neurosurgery, University of Florida, Gainesville, Florida 32611, USA

4. Department of Otolaryngology, University of Florida, Gainesville, Florida 32611, USA

Abstract

Hemangioblastoma are benign, vascularized cranial tumors caused by autosomal dominant inherited von Hippel-Lindau disease or can appear sporadically. This review will investigate current and emerging treatments for cerebral tumors. It will focus on the current and, more importantly, developing hemangioblastoma treatments. Surgical resectioning and radiotherapy are effective treatment options for cerebral tumors, whereas chemotherapies are not commonly used due to their limited ability to penetrate the blood-brain barrier. Recent chemotherapies have shown promise, but further research is needed to determine the efficacy as a treatment for hemangioblastomas. New advances in brachytherapy and immunotherapy are considered promising treatment options for hemangioblastoma. This review aims to offer valuable insights into the latest developments in hemangioblastoma treatments.

Publisher

Open Exploration Publishing

Subject

General Medicine,General Earth and Planetary Sciences,General Environmental Science,General Medicine,Ocean Engineering,General Medicine,General Medicine,General Medicine,General Medicine,General Earth and Planetary Sciences,General Environmental Science,General Medicine

Reference83 articles.

1. Jejurkar MA, Lagad SG, Ranjan R. Recurrence of sporadic intracranial cerebellar hemangioblastoma: case report and literature review. Neurol India. 2021;69:508–10. [PMID: 33904491 DOI: 10.4103/0028-3886.314560]

2. Schattner A, Cagnano E, Dubin I. Cerebellar hemangioblastoma. Am J Med. 2018;131:e15–6. [PMID: 28807712 DOI: 10.1016/j.amjmed.2017.07.027]

3. Roach J, Livermore L, Plaha P. Endoscope-assisted resection for cystic cerebellar hemangioblastomas. World Neurosurg. 2022;167:e217–21. [PMID: 35944859 DOI: 10.1016/j.wneu.2022.07.132]

4. Jeon C, Choi JW, Kong DS, Nam DH, Lee JI, Seol HJ. Treatment strategy for giant solid hemangioblastomas in the posterior fossa: a retrospective review of 13 consecutive cases. World Neurosurg. 2022;158:e214–24. [PMID: 34728396 DOI: 10.1016/j.wneu.2021.10.169]

5. Ren H, Wang Y, Ma Y, Huang Y. Microsurgical management of cerebellar hemangioblastoma via the suboccipital keyhole approach. Asian J Surg. 2022;45:2876–7. [PMID: 35778247 DOI: 10.1016/j.asjsur.2022.06.081]